Today: 7 July 2026
DBS stock price ends week near a 52-week high as Fed decision and Feb 9 earnings loom
25 January 2026
1 min read

DBS stock price ends week near a 52-week high as Fed decision and Feb 9 earnings loom

SINGAPORE, Jan 25, 2026, 14:48 SGT — Market closed

  • DBS shares closed up 1% at S$58.65, lingering just 1% below their 52-week high
  • After the Bank of Japan held steady, global rate signals drew fresh scrutiny ahead of the Fed’s January 27-28 meeting
  • DBS will report its fourth-quarter results on Feb 9, with investors closely watching margins and dividends.

DBS Group Holdings Ltd shares ended Friday at S$58.65, gaining 0.98% after moving between S$57.90 and S$58.83 earlier in the day. The stock is still about 1% below its 52-week high of S$59.25.

This change matters because rate forecasts could shift once more this week, affecting bank valuations directly. DBS will report its quarterly results in two weeks, where it must outline its perspective on what “normal” earnings mean as borrowing costs ease.

Asian risk appetite improved Friday after the Bank of Japan kept rates unchanged but revised its growth and inflation forecasts upward, hinting at possible gradual tightening ahead. “The tone appears hawkish,” said David Chao, global market strategist for Asia-Pacific at Invesco in Singapore. Reuters

For DBS, the spotlight remains firmly on net interest margin — the difference between what it earns on loans and pays on deposits. In the latest quarter, both DBS and Singapore peer UOB reported margin squeeze as interest rates softened, a headache investors have yet to shake off.

All eyes are on the U.S. Federal Reserve’s Jan. 27-28 meeting, with the policy decision and press conference set for Jan. 28. Any shift in the Fed’s language could ripple through global rate markets and alter banks’ lending spreads.

DBS will unveil its fourth-quarter 2025 results on Feb. 9. Investors are focused on margin pressure, credit costs, and the bank’s strategy for capital returns—particularly the dividend it intends to uphold throughout the current cycle.

The setup still holds risks. Should interest rates fall more quickly than anticipated, margins could tighten. Plus, a slowdown in regional growth might push bad-loan charges higher, eating into earnings that appear stable—right up until they don’t.

The stock’s next key moment arrives Monday in the Singapore session, with traders watching global rates and Asia FX closely after the BOJ’s announcement. The bigger milestone, though, is Feb. 9, when DBS rolls out its report and new data lands for investors to weigh.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Celestica (TSX:CLS) taps Steven Dorwart as new CCS president, shares up 136% in 12 months
    July 7, 2026, 4:36 PM EDT. Celestica (TSX:CLS) named Steven Dorwart president of its Connectivity and Cloud Solutions segment, replacing Jason Phillips. Dorwart has spent 21 years at the company and steps in at a time when AI and cloud infrastructure drive CCS business. Celestica shares traded at CA$498.11, up 20.1% this year and 136.7% over 12 months, showing strong market interest in the CCS unit. The price slipped 3.9% in the past month. Dorwart's performance will be key for revenue and margin trends in AI and cloud. Analyst consensus targets hover near CA$648.86, with Simply Wall St still flagging valuation risks as the stock trades roughly 58% premium to fair value. Investors should look for quality cash flow with high non-cash earnings in focus and watch for Dorwart's influence in upcoming earnings calls.
HSBC share price dips as Hang Seng Bank delisting nears — dates investors are watching
Previous Story

HSBC share price dips as Hang Seng Bank delisting nears — dates investors are watching

Nestle stock faces Monday test after France probes baby deaths tied to recalled formula
Next Story

Nestle stock faces Monday test after France probes baby deaths tied to recalled formula

Go toTop